Patents Assigned to Placon Therapeutics, Inc.
  • Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof
    Patent number: 10472380
    Abstract: The present disclosure relates to novel platinum compositions having a heterocycle ligand and nanoparticles and methods using such compositions, e.g. for treating cancer.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: November 12, 2019
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Adam H. Brockman, Mark T. Bilodeau, Benoît Moreau, Edward R. Lee
  • Platinum compounds, compositions, and uses thereof
    Patent number: 10342801
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: July 9, 2019
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Rossitza G. Alargova, Mark T. Bilodeau, Richard Wooster, Benoît Moreau, Kerry Whalen, J. Michael Ramstack, Danielle N. Rockwood, Patrick Lim Soo, Sukhjeet Singh, Tsun P. Au Yeung, Charles-Andre Lemelin, Linda M. Custer
  • Platinum compounds, compositions, and uses thereof
    Patent number: 10322137
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: June 18, 2019
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoit Moreau, Adam H. Brockman, Kristan Meetze, Kerry Whalen, Richard Wooster, Rossitza G. Alargova
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 10287308
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one polar moiety as a ligand.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: May 14, 2019
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoît Moreau
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 10111853
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: October 30, 2018
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood, Rajesh Shinde, Patrick Lim Soo, Benoît Moreau
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 10011622
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: July 3, 2018
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman
  • Platinum compounds, compositions, and uses thereof
    Patent number: 9937187
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: April 10, 2018
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman, Kristan Meetze, Kerry Whalen, Richard Wooster, Rossitza G. Alargova
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 9738672
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one polar moiety as a ligand.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: August 22, 2017
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Benoît Moreau
  • Compounds, compositions, and methods for the treatment of cancers
    Patent number: 9556214
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: January 31, 2017
    Assignee: PLACON THERAPEUTICS, INC.
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danille N. Rockwood, Rajesh Shinde, Patrick Lim Soo, Benoît Moreau
  • Platinum compounds, compositions, and uses thereof
    Patent number: 9403858
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target cell population, and/or derivatives/analogs/mimics thereof.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: August 2, 2016
    Assignee: Placon Therapeutics, Inc.
    Inventors: Mark T. Bilodeau, Benoît Moreau, Adam H. Brockman